Wendling et al. [68] demonstrated that mildly elevated ICAM-1 levels correlated with markers of disease activity (i.e., erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), disease severity score) in patients with spondyloarthropathies. Here, ICAM1 is linked to spondyloarthropathy.